Location: Hellerup, Denmark
CIK: 0001388325 · Show all filings
Period: Q2 2014 (← Previous) (Next →)
Filing Date: Nov 14, 2014
Total Value: $1.048B
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDS | 2,979,100 | $303M | 28.9% | $101.77 | $57.39 | — | TOTAL STK MKT | 922908769 |
| — | OPHTHOTECH CORP | 6,910,489 | $292M | 27.9% | $42.31 | $32.35 | — | COM | 683745103 |
| VGK | VANGUARD INTL EQUITY INDEX F | 2,101,000 | $126M | 12.0% | $59.95 | $45.01 | — | FTSE EUROPE ETF | 922042874 |
| INGN | INOGEN INC | 5,419,449 | $122M | 11.7% | $22.56 * | $17.78 | -6.8% | COM | 45780L104 |
| — | ALDER BIOPHARMACEUTICALS INC | 3,201,183 | $64.25M | 6.1% | $20.07 | $20.07 | — | COM | 014339105 |
| AKBA | AKEBIA THERAPEUTICS INC | 1,516,387 | $42.14M | 4.0% | $27.79 * | $24.08 | 0.0% | COM | 00972D105 |
| — | FLEXION THERAPEUTICS INC ⚠ | 1,783,131 | $24.04M | 2.3% | $13.48 | $16.45 | — | — | 33938J106 |
| — | FLEXION THERAPEUTICS ⚠ | 1,783,131 | $24.04M | 2.3% | $13.48 | $16.45 | — | COM | 33938J106 |
| — | WRIGHT MED GROUP INC | 585,759 | $18.39M | 1.8% | $31.40 | $23.81 | — | COM | 98235T107 |
| — | TETRAPHASE PHARMACEUTICALS INC | 900,000 | $12.14M | 1.2% | $13.49 | $13.52 | — | COM | 88164N105 |
| — | TETRAPHASE PHARMACEUTICALS INC | 900,000 | $12.14M | 1.2% | $13.49 | $13.52 | — | COM | 88165N105 |
| — | WRIGHT MED GROUP INC | 4,720,065 | $7.033M | 0.7% | $1.49 | $2.50 | — | RIGHT 03/01/2019 | 98235T115 |